Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Kidney Int ; 105(6): 1157-1159, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38777398

RESUMO

Chen et al. identify dysregulation of the transcriptional activator Yes-associated protein in the podocytes of diabetic mouse and human kidneys. Podocyte Yes-associated protein deficiency led to downregulation of the key transcription factor Wilms' tumor 1, and worsened podocyte injury in a mouse model of diabetic kidney injury. Yes-associated protein may therefore play a critical role in diabetic podocyte injury via regulation of Wilms' tumor 1 expression.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal , Nefropatias Diabéticas , Podócitos , Fatores de Transcrição , Proteínas WT1 , Proteínas de Sinalização YAP , Podócitos/metabolismo , Podócitos/patologia , Animais , Humanos , Proteínas de Sinalização YAP/metabolismo , Fatores de Transcrição/metabolismo , Fatores de Transcrição/genética , Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Proteínas Adaptadoras de Transdução de Sinal/genética , Proteínas WT1/metabolismo , Proteínas WT1/genética , Camundongos , Nefropatias Diabéticas/patologia , Nefropatias Diabéticas/metabolismo , Nefropatias Diabéticas/etiologia , Fosfoproteínas/metabolismo , Fosfoproteínas/genética , Proteínas de Ciclo Celular/metabolismo , Proteínas de Ciclo Celular/genética
2.
Diabetes ; 72(12): 1751-1765, 2023 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-37699387

RESUMO

Caspases are cysteine-aspartic proteases that were initially discovered to play a role in apoptosis. However, caspase 8, in particular, also has additional nonapoptotic roles, such as in inflammation. Adipocyte cell death and inflammation are hypothesized to be initiating pathogenic factors in type 2 diabetes. Here, we examined the pleiotropic role of caspase 8 in adipocytes and obesity-associated insulin resistance. Caspase 8 expression was increased in adipocytes from mice and humans with obesity and insulin resistance. Treatment of 3T3-L1 adipocytes with caspase 8 inhibitor Z-IETD-FMK decreased both death receptor-mediated signaling and targets of nuclear factor κ-light-chain-enhancer of activated B (NF-κB) signaling. We generated novel adipose tissue and adipocyte-specific caspase 8 knockout mice (aP2Casp8-/- and adipoqCasp8-/-). Both males and females had improved glucose tolerance in the setting of high-fat diet (HFD) feeding. Knockout mice also gained less weight on HFD, with decreased adiposity, adipocyte size, and hepatic steatosis. These mice had decreased adipose tissue inflammation and decreased activation of canonical and noncanonical NF-κB signaling. Furthermore, they demonstrated increased energy expenditure, core body temperature, and UCP1 expression. Adipocyte-specific activation of Ikbkb or housing mice at thermoneutrality attenuated improvements in glucose tolerance. These data demonstrate an important role for caspase 8 in mediating adipocyte cell death and inflammation to regulate glucose and energy homeostasis. ARTICLE HIGHLIGHTS: Caspase 8 is increased in adipocytes from mice and humans with obesity and insulin resistance. Knockdown of caspase 8 in adipocytes protects mice from glucose intolerance and weight gain on a high-fat diet. Knockdown of caspase 8 decreases Fas signaling, as well as canonical and noncanonical nuclear factor κ-light-chain-enhancer of activated B (NF-κB) signaling in adipose tissue. Improved glucose tolerance occurs via reduced activation of NF-κB signaling and via induction of UCP1 in adipocytes.


Assuntos
Diabetes Mellitus Tipo 2 , Resistência à Insulina , Humanos , Masculino , Feminino , Animais , Camundongos , NF-kappa B/metabolismo , Resistência à Insulina/genética , Caspase 8/genética , Caspase 8/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Camundongos Knockout , Adipócitos/metabolismo , Obesidade/genética , Obesidade/metabolismo , Dieta Hiperlipídica/efeitos adversos , Inflamação/metabolismo , Glucose/metabolismo , Apoptose/genética
3.
Transplant Direct ; 8(6): e1334, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35721457

RESUMO

Background: Organ stiffening can be caused by inflammation and fibrosis, processes that are common causes of transplant kidney dysfunction. Magnetic resonance elastography (MRE) is a contrast-free, noninvasive imaging modality that measures kidney stiffness. The objective of this study was to assess the ability of MRE to serve as a prognostic factor for renal outcomes. Methods: Patients were recruited from the St Michael's Hospital Kidney Transplant Clinic. Relevant baseline demographic, clinical, and Banff histologic information, along with follow-up estimated glomerular filtration rate (eGFR) data, were recorded. Two-dimensional gradient-echo MRE imaging was performed to obtain kidney "stiffness" maps. Binary logistic regression analyses were performed to examine for relationships between stiffness and microvascular inflammation score. Linear mixed-effects modeling was used to assess the relationship between stiffness and eGFR change over time controlling for other baseline variables. A G2-likelihood ratio Chi-squared test was performed to compare between the baseline models with and without "stiffness." Results: Sixty-eight transplant kidneys were scanned in 66 patients (mean age 56 ± 12 y, 24 females), with 38 allografts undergoing a contemporaneous biopsy. Mean transplant vintage was 7.0 ± 6.8 y. In biopsied allografts, MRE-derived allograft stiffness was associated only with microvascular inflammation (Banff g + ptc score, Spearman ρ = 0.43, P = 0.01), but no other histologic parameters. Stiffness was negatively associated with eGFR change over time (Stiffness × Time interaction ß = -0.80, P < 0.0001), a finding that remained significant even when adjusted for biopsy status and baseline variables (Stiffness × Time interaction ß = -0.46, P = 0.04). Conversely, the clinical models including "stiffness" showed significantly better fit (P = 0.04) compared with the baseline clinical models without "stiffness." Conclusions: MRE-derived renal stiffness provides important prognostic information regarding renal function loss for patients with allograft dysfunction, over and above what is provided by current clinical variables.

4.
Nat Commun ; 12(1): 2409, 2021 04 23.
Artigo em Inglês | MEDLINE | ID: mdl-33893302

RESUMO

During cytokinesis, the actin cytoskeleton is partitioned into two spatially distinct actin isoform specific networks: a ß-actin network that generates the equatorial contractile ring, and a γ-actin network that localizes to the cell cortex. Here we demonstrate that the opposing regulation of the ß- and γ-actin networks is required for successful cytokinesis. While activation of the formin DIAPH3 at the cytokinetic furrow underlies ß-actin filament production, we show that the γ-actin network is specifically depleted at the cell poles through the localized deactivation of the formin DIAPH1. During anaphase, CLIP170 is delivered by astral microtubules and displaces IQGAP1 from DIAPH1, leading to formin autoinhibition, a decrease in cortical stiffness and localized membrane blebbing. The contemporaneous production of a ß-actin contractile ring at the cell equator and loss of γ-actin from the poles is required to generate a stable cytokinetic furrow and for the completion of cell division.


Assuntos
Citoesqueleto de Actina/metabolismo , Actinas/metabolismo , Citocinese , Microtúbulos/metabolismo , Fuso Acromático/metabolismo , Centrossomo/metabolismo , Forminas/genética , Forminas/metabolismo , Células HeLa , Humanos , Microscopia de Força Atômica , Microscopia de Fluorescência , Proteínas Associadas aos Microtúbulos/genética , Proteínas Associadas aos Microtúbulos/metabolismo , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Ligação Proteica , Proteínas Ativadoras de ras GTPase/genética , Proteínas Ativadoras de ras GTPase/metabolismo , Proteína rhoA de Ligação ao GTP/genética , Proteína rhoA de Ligação ao GTP/metabolismo
5.
Small ; 17(20): e2100345, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33811441

RESUMO

Nanotechnology currently enables the fabrication of uniform solid nanoparticles and liquid nano-emulsions, but not uniform gaseous nanobubbles (NBs). In this article, for the first time, a method based on microfluidics that directly produces monodisperse NBs is reported. Specifically, a two-component gas mixture of water-soluble nitrogen and water-insoluble octafluoropropane as the gas phase are used in a microfluidic bubble generator. First, monodisperse microbubbles (MBs) with a classical microfluidic flow-focusing junction is generated, then the MBs shrink down to ≈100 nm diameter, due to the dissolution of the water-soluble components in the gas mixture. The degree of shrinkage is controlled by tuning the ratio of water-soluble to water-insoluble gas components. This technique maintains the monodispersity of the NBs, and enables precise control of the final NB size. It is found that the monodisperse NBs show better homogeneity than polydisperse NBs in in vitro ultrasound imaging experiments. Proof-of-concept in vivo kidney imaging is performed in live mice, demonstrating enhanced contrast using the monodisperse NBs. The NB monodispersity and imaging results make microfluidically generated NBs promising candidates as ultrasound contrast and molecular imaging agents.


Assuntos
Microbolhas , Microfluídica , Nanotecnologia , Animais , Rim/diagnóstico por imagem , Camundongos , Imagem Molecular , Solubilidade , Ultrassonografia
6.
Curr Opin Nephrol Hypertens ; 29(6): 599-607, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-33009130

RESUMO

PURPOSE OF REVIEW: Fibrosis is an important biomarker of chronic kidney injury, and a powerful predictor of renal outcome. Currently, the only method for measuring fibrotic burden is histologic analysis, which requires a kidney biopsy in humans, or kidney removal in animal models. These requirements have not only hindered our ability to manage patients effectively, but have also prevented a full understanding of renal fibrosis pathogenesis, and slowed the translation of new antifibrotic agents. The development of noninvasive fibrosis imaging tools could thus transform both clinical care and renal fibrosis research. RECENT FINDINGS: Conventional imaging modalities have historically failed to image fibrosis successfully. However, recent exciting technological advances have greatly enhanced their capabilities. New techniques, for example, may allow imaging of the physical consequences of scarring, as surrogate measures of renal fibrosis. Similarly, other groups have developed ways to directly image extracellular matrix, either with the use of contrast-enhanced probes, or using matrix components as endogenous contrast agents. SUMMARY: New developments in imaging technology have the potential to transform our ability to visualize renal fibrosis and to monitor its progression. In doing so, these advances could have major implications for kidney disease care, the development of new antiscarring agents, and our understanding of renal fibrosis in general.


Assuntos
Rim/diagnóstico por imagem , Rim/patologia , Animais , Biomarcadores , Matriz Extracelular/patologia , Fibrose , Humanos
7.
BMC Nephrol ; 21(1): 285, 2020 07 18.
Artigo em Inglês | MEDLINE | ID: mdl-32682403

RESUMO

BACKGROUND: While histopathologic changes correlate with functional impairment in cross-sectional studies of diabetic nephropathy (DN), whether these findings predict future rate of kidney function loss remains uncertain. We thus sought to examine the relationship between kidney histopathology, incidence of end-stage kidney disease (ESKD), and rate of estimated glomerular filtration rate (eGFR) loss in DN. METHODS: In this longitudinal cohort study, we studied 50 adults diagnosed with biopsy-proven DN. We analyzed the histopathologic parameters of each patient's kidney biopsy, as defined by the Renal Pathology Society classification system for DN, and tracked all available eGFR measurements post-biopsy. We additionally collected baseline clinical parameters (at the time of biopsy), including eGFR, albumin-to-creatinine ratio (ACR), and hemoglobin A1c. Multivariable linear regression was used to assess the relationship between histologic and clinical parameters at the time of the biopsy and eGFR slope. Kaplan-Meier curves and Cox regression were used to evaluate the association between histologic and clinical parameters and ESKD incidence. RESULTS: Progression to ESKD was associated with worsening interstitial fibrosis score (p = 0.05), lower baseline eGFR (p = 0.02), higher ACR (p = 0.001), and faster eGFR decline (p < 0.001). The rate of eGFR decline did not associate with any histologic parameter. Baseline ACR was the only studied variable correlating with eGFR slope (rho = - 0.41). CONCLUSIONS: Renal histology predicts ultimate progression to ESKD, but not the rate of progression. Future work is required to identify novel predictors of rapid functional decline in patients with diabetic nephropathy.


Assuntos
Nefropatias Diabéticas/patologia , Falência Renal Crônica/patologia , Rim/patologia , Insuficiência Renal Crônica/patologia , Idoso , Atrofia , Creatinina/metabolismo , Diabetes Mellitus Tipo 1/complicações , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/metabolismo , Nefropatias Diabéticas/etiologia , Nefropatias Diabéticas/metabolismo , Progressão da Doença , Feminino , Fibrose , Taxa de Filtração Glomerular , Hemoglobinas Glicadas/metabolismo , Humanos , Falência Renal Crônica/etiologia , Falência Renal Crônica/metabolismo , Túbulos Renais/patologia , Modelos Lineares , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Modelos de Riscos Proporcionais , Insuficiência Renal Crônica/etiologia , Insuficiência Renal Crônica/metabolismo , Albumina Sérica/metabolismo , Fatores de Tempo
8.
Curr Res Transl Med ; 68(4): 225-236, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32499177

RESUMO

BACKGROUND: Current uncertainties about the similarity between human diseases and their experimental models are hampering the development of new therapies. This is especially the case for diabetic kidney disease (DKD), the most common cause of end-stage kidney disease. To better understand the nature of the commonality between humans and their mouse models, we posed the question: in diabetic kidney disease are transcriptional profiles primarily disease-specific or species-specific? METHODS: We performed a meta-comparison of the glomerular transcriptomic characteristics of 133 human and 66 mouse samples including five human kidney diseases and five mouse models, validating expression patterns of a central node by immunohistochemistry. FINDINGS: Principal component analysis controlled for mouse background, revealed that gene expression changes in glomeruli from humans with DKD are more similar to those of diabetic mice than they are to other human glomerular diseases. This similarity enabled the construction of a discriminatory classifier that distinguishes diabetic glomeruli from other glomerular phenotypes regardless of their species of origin. To identify where the commonality between mice and humans with diabetes lies, networks of maximally perturbed protein interactions were examined, identifying a central role for the epidermal growth factor receptor (EGFR). By immunohistochemical staining, we found EGFR to be approximately doubled in its glomerular expression in both humans and mice. INTERPRETATION: These findings indicate that diabetic mouse models do mimic some of the features of human kidney disease, at least with respect to their glomerular transcriptomic signatures, and they identify EGFR as being a central player in this inter-species overlap.


Assuntos
Nefropatias Diabéticas , Falência Renal Crônica , Glomérulos Renais , Transcriptoma , Animais , Nefropatias Diabéticas/diagnóstico , Nefropatias Diabéticas/genética , Modelos Animais de Doenças , Receptores ErbB/metabolismo , Humanos , Falência Renal Crônica/diagnóstico , Falência Renal Crônica/genética , Glomérulos Renais/metabolismo , Camundongos
9.
Heart ; 105(11): 855-863, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-30514732

RESUMO

OBJECTIVE: The relationship between right ventricular (RV) fibrosis and right heart reverse remodelling following pulmonary valve replacement (PVR) has not been well studied in adults with repaired tetralogy of Fallot (rTOF). Our aims were to histologically quantify RV fibrosis and to explore the relationship between fibrosis severity and cardiac remodelling post-PVR. METHODS: Adults with rTOF and pre-PVR cardiovascular (CMR) imaging were consented to procurement of RV muscle during PVR. Samples were stained with picrosirius red to quantify collagen volume fraction. Clinical data at baseline and at last follow-up were reviewed. Adverse cardiovascular outcomes included death, sustained arrhythmia and heart failure. RESULTS: Fifty-three patients (male 58%, 38±11 years) were studied. Those with severe fibrosis (collagen volume fraction >11.0%, n=13) had longer aortic cross-clamp times at initial repair compared with the remainder of the population (50 vs 33 min, p=0.018) and increased RV mass:volume ratio pre-PVR (0.20 vs 0.18 g/mL, p=0.028). Post-PVR, the severe fibrosis group had increased indexed RV end-systolic volume index (RVESVi) (74 vs 66 mL/m2, p=0.044), decreased RVESVi change (Δ29 vs Δ45 mL/m2, p=0.005), increased RV mass (34 vs 25 g/m2, p=0.023) and larger right atrial (RA) area (21 vs 17 cm2, p=0.021). A trend towards increased heart failure events was observed in the severe fibrosis group (15% vs 0%, p=0.057). CONCLUSIONS: Severe RV fibrosis was associated with increased RVESVi, RV mass and RA area post-PVR in rTOF. Further study is required to define the impact of fibrosis and persistent right heart enlargement on clinical outcomes.


Assuntos
Cardiomiopatias/diagnóstico , Implante de Prótese de Valva Cardíaca/efeitos adversos , Ventrículos do Coração/fisiopatologia , Miocárdio/patologia , Insuficiência da Valva Pulmonar/cirurgia , Valva Pulmonar/cirurgia , Remodelação Ventricular , Adulto , Biópsia , Cardiomiopatias/etiologia , Cardiomiopatias/fisiopatologia , Feminino , Fibrose/diagnóstico , Fibrose/etiologia , Fibrose/fisiopatologia , Seguimentos , Ventrículos do Coração/diagnóstico por imagem , Humanos , Imagem Cinética por Ressonância Magnética/métodos , Masculino , Insuficiência da Valva Pulmonar/diagnóstico , Insuficiência da Valva Pulmonar/fisiopatologia , Estudos Retrospectivos , Tetralogia de Fallot/cirurgia , Função Ventricular Direita/fisiologia
10.
Clin J Am Soc Nephrol ; 12(10): 1671-1679, 2017 Oct 06.
Artigo em Inglês | MEDLINE | ID: mdl-28855238

RESUMO

BACKGROUND AND OBJECTIVES: Fibrosis is a major cause of kidney allograft injury. Currently, the only means of assessing allograft fibrosis is by biopsy, an invasive procedure that samples <1% of the kidney. We examined whether magnetic resonance elastography, an imaging-based measure of organ stiffness, could noninvasively estimate allograft fibrosis and predict progression of allograft dysfunction. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Kidney allograft recipients >1 year post-transplant undergoing an allograft biopsy first underwent free-breathing, flow-compensated magnetic resonance elastography on a 3.0-T magnetic resonance imaging scanner. Each patient had serial eGFR measurements after the elastography scan for a follow-up period of up to 1 year. The mean stiffness value of the kidney allograft was compared with both the histopathologic Banff fibrosis score and the rate of eGFR change during the follow-up period. RESULTS: Sixteen patients who underwent magnetic resonance elastography and biopsy were studied (mean age: 54±9 years old). Whole-kidney mean stiffness ranged between 3.5 and 7.3 kPa. Whole-kidney stiffness correlated with biopsy-derived Banff fibrosis score (Spearman rho =0.67; P<0.01). Stiffness was heterogeneously distributed within each kidney, providing a possible explanation for the lack of a stronger stiffness-fibrosis correlation. We also found negative correlations between whole-kidney stiffness and both baseline eGFR (Spearman rho =-0.65; P<0.01) and eGFR change over time (Spearman rho =-0.70; P<0.01). Irrespective of the baseline eGFR, increased kidney stiffness was associated with a greater eGFR decline (regression r2=0.48; P=0.03). CONCLUSIONS: Given the limitations of allograft biopsy, our pilot study suggests the potential for magnetic resonance elastography as a novel noninvasive measure of whole-allograft fibrosis burden that may predict future changes in kidney function. Future studies exploring the utility and accuracy of magnetic resonance elastography are needed.


Assuntos
Técnicas de Imagem por Elasticidade , Transplante de Rim/efeitos adversos , Rim/diagnóstico por imagem , Rim/cirurgia , Imageamento por Ressonância Magnética , Adulto , Idoso , Aloenxertos , Biópsia , Feminino , Fibrose , Taxa de Filtração Glomerular , Humanos , Rim/patologia , Rim/fisiopatologia , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Valor Preditivo dos Testes , Estudos Prospectivos , Fatores de Tempo , Resultado do Tratamento
11.
Clin J Am Soc Nephrol ; 12(6): 1019-1028, 2017 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-28298435

RESUMO

A key contributor to the progression of nearly all forms of CKD is fibrosis, a largely irreversible process that drives further kidney injury. Despite its importance, clinicians currently have no means of noninvasively assessing renal scar, and thus have historically relied on percutaneous renal biopsy to assess fibrotic burden. Although helpful in the initial diagnostic assessment, renal biopsy remains an imperfect test for fibrosis measurement, limited not only by its invasiveness, but also, because of the small amounts of tissue analyzed, its susceptibility to sampling bias. These concerns have limited not only the prognostic utility of biopsy analysis and its ability to guide therapeutic decisions, but also the clinical translation of experimental antifibrotic agents. Recent advances in imaging technology have raised the exciting possibility of magnetic resonance imaging (MRI)-based renal scar analysis, by capitalizing on the differing physical features of fibrotic and nonfibrotic tissue. In this review, we describe two key fibrosis-induced pathologic changes (capillary loss and kidney stiffening) that can be imaged by MRI techniques, and the potential for these new MRI-based technologies to noninvasively image renal scar.


Assuntos
Cicatriz/diagnóstico por imagem , Técnicas de Imagem por Elasticidade/métodos , Nefropatias/diagnóstico por imagem , Rim/diagnóstico por imagem , Imageamento por Ressonância Magnética/métodos , Imagem de Perfusão/métodos , Animais , Biópsia , Cicatriz/patologia , Cicatriz/fisiopatologia , Meios de Contraste/administração & dosagem , Fibrose , Humanos , Rim/irrigação sanguínea , Rim/patologia , Nefropatias/patologia , Nefropatias/fisiopatologia , Valor Preditivo dos Testes , Prognóstico , Circulação Renal
12.
Artigo em Inglês | MEDLINE | ID: mdl-27638853

RESUMO

HYPOTHESIS/INTRODUCTION: Renal fibrovascular injury often persists in chronic kidney disease patients treated with renin-angiotensin system blockers. Intriguingly, early outgrowth cell-derived factor infusion also inhibits chronic renal injury. We sought to determine whether early outgrowth cell-derived factor administration provides further renoprotection when added to renin-angiotensin system blockade. MATERIALS AND METHODS: Conditioned medium was generated by incubating rat early outgrowth cells with serum-free endothelial basal medium-2 to collect their secreted factors. Subtotal nephrectomy rats received enalapril 0.5 mg/L in drinking water or placebo, beginning 8 weeks post-surgery. Four weeks later, enalapril-treated rats received intravenous injections of either conditioned medium or control endothelial basal medium-2 for 2 weeks. Glomerular filtration rate, urinary protein excretion and renal structure were assessed 4 weeks later at 16 weeks post-surgery. RESULTS: Enalapril-treated subtotal nephrectomy rats receiving control endothelial basal medium-2 injections experienced only partial renoprotection when compared to vehicle-treated subtotal nephrectomy rats. In contrast, conditioned medium infusion, when administered in addition to enalapril, attenuated the progression of renal dysfunction in subtotal nephrectomy rats, improving glomerular filtration rate and reducing proteinuria without affecting blood pressure. CONCLUSIONS: Early outgrowth cell-derived factors exert additive renoprotective effects on top of angiotensin-converting enzyme inhibitor therapy in experimental chronic kidney disease, providing the rationale for clinical trials of early outgrowth cell-based therapies for chronic kidney disease.


Assuntos
Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Rim/patologia , Substâncias Protetoras/uso terapêutico , Insuficiência Renal Crônica/tratamento farmacológico , Células-Tronco/metabolismo , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Animais , Meios de Cultivo Condicionados/farmacologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Enalapril/farmacologia , Enalapril/uso terapêutico , Células Endoteliais/efeitos dos fármacos , Células Endoteliais/patologia , Taxa de Filtração Glomerular/efeitos dos fármacos , Rim/efeitos dos fármacos , Rim/fisiopatologia , Substâncias Protetoras/farmacologia , Ratos Endogâmicos F344 , Insuficiência Renal Crônica/patologia , Insuficiência Renal Crônica/fisiopatologia , Células-Tronco/efeitos dos fármacos
13.
Artigo em Inglês | MEDLINE | ID: mdl-26568839

RESUMO

BACKGROUND: Bone marrow-derived early outgrowth cells (EOCs) secrete soluble factors that exert potent renoprotective effects, such that infusion of their conditioned medium recapitulates the affects of the cells themselves. OBJECTIVES: The objective of this study is to test whether the protective effect of conditioned medium infusion wanes with time and whether tachyphylaxis occurs with repeated administration. DESIGN: This is a placebo-controlled animal study. SETTING: The study was conducted at St. Michael's Hospital, Toronto, Ontario, Canada. SUBJECTS: Fischer 344 (F344) rats were used in this study. MEASUREMENTS: The following were measured: (1) urinary protein:creatinine ratio, (2) glomerular filtration rate, (3) systolic blood pressure, (4) body weight, (5) glomerular endothelial cell density, and (6) glomerular and tubulointerstitial type IV collagen deposition. METHODS: Subtotally nephrectomized F344 rats, a model of progressive chronic kidney disease, were randomized 4 weeks post-surgery to receive thrice-weekly intravenous injections of concentrated EOC-conditioned medium (EOC CM) or unconditioned medium (UCM) over 2 weeks. Three animal groups were studied, according to whether they were administered conditioned medium: once (Initial Therapy Only group), twice (Repeat Therapy group), or not at all (No Therapy group). RESULTS: Following initial therapy, EOC CM-treated animals excreted less urinary protein, a marker of renal injury, than their UCM-treated counterparts. At 10 weeks post-subtotal nephrectomy, however, mean urinary protein excretion in conditioned medium-treated animals was fourfold greater than at the completion of the initial treatment course. At this time point, conditioned medium-treated animals were randomized to receive a second course of either conditioned medium (Repeat Therapy group) or unconditioned medium (Initial Therapy Only group). At study end (14 weeks post-subtotal nephrectomy), Repeat Therapy animals demonstrated higher glomerular filtration rate, less proteinuria, preserved renal microvasculature, and diminished fibrosis when compared with the No Therapy group. Initial Therapy Only animals exhibited an intermediate effect. LIMITATIONS: Testing the effect of EOC-conditioned medium in a single model of chronic kidney disease (CKD) has limitations. CONCLUSIONS: These findings suggest that early outgrowth cell-derived factors, while renoprotective, have a limited duration of action. Repeated administration of these factors, however, is able to extend the duration of efficacy and attenuate the progression of experimental chronic kidney disease.


CONTEXTE: Les cellules à croissance précoce (CCP) provenant de la moelle osseuse sécrètent des facteurs solubles qui procurent des effets néphroprotecteurs très efficaces. Une simple infusion de milieu de culture conditionné par des CCP permet d'instaurer des effets protecteurs dans les cellules rénales. BUT DE L'ÉTUDE: Vérifier si l'effet néphroprotecteur d'une infusion de milieu conditionné décline dans le temps et déterminer si l'administration répétée engendre une tachyphylaxie. TYPE D'ÉTUDE: Essai contrôlé par placebo sur modèles animaux. ÉTABLISSEMENT: Hôpital St. Micheal's de Toronto, ON, Canada. SUJETS: Rats Fisher (F344). MESURES: (1) le ratio urinaire « protéines/créatinine ¼ (2) le débit de filtration glomérulaire (3) la pression systolique (4) le poids corporel (5) la densité des cellules endothéliales glomérulaires et (6) le dépôt tubulo-interstitiel et glomérulaire de collagène de type IV. MÉTHODE: Quatre semaines suivant la chirurgie, deux groupes expérimentaux ont été formés par randomisation de rats F344 partiellement néphrectomisés (un modèle utilisé pour l'étude de l'insuffisance rénale chronique et dégénérative). Durant 2 semaines, les animaux recevaient 3 injections intraveineuses par semaine d'un concentré de milieu conditionné par cellules à croissance précoce (MC-CCP) ou d'un concentré de milieu non conditionné (MNC). Les animaux du groupe MC-CCP ont, plus tard au cours de l'étude, été divisés en 2 sous-groupes. L'un d'eux a reçu une deuxième série d'injections de MC-CCP et l'autre, de MNC. Ainsi, 3 groupes ont été étudiés, selon qu'ils ont été traités au MC-CCP une seule fois (groupe « Traitement Initial Seulement ¼), deux fois (groupe « Traitement Répété ¼) ou en aucun temps (groupe « Non Traité ¼). RÉSULTATS: Dès le traitement initial, une diminution de l'excrétion urinaire de protéines (un indicateur de lésions aux reins) a été observée chez les sujets du groupe MC-CCP par rapport aux niveaux de leurs homologues du groupe MNC. Par contre, la moyenne d'excrétion urinaire de protéines chez les sujets du groupe MC-CCP avait tout de même quadruplé, 10 semaines suivant la chirurgie, par rapport aux taux mesurés après la première ronde de traitements. À ce stade de l'étude, les sujets du groupe MC-CCP ont été divisés et randomisés en deux sous-groupes à qui une deuxième ronde de traitements, soit par MC-CCP (groupe « Traitement Répété ¼), soit par MNC (groupe « Traitement Initial Seulement ¼) a été administrée. Au terme de l'étude (14 semaines suivant la chirurgie), les animaux du groupe « Traitement Répété ¼ ont démontré un débit de filtration glomérulaire supérieur, une diminution de la protéinurie, une préservation de la microvasculature rénale et une réduction de la fibrose, lorsque comparés au groupe non traité. Les animaux du groupe « Traitement Initial Seulement ¼ ont montré des résultats intermédiaires. LIMITATIONS: L'effet d'un traitement avec MC-CCP n'a été testé que dans un seul modèle expérimental d'insuffisance rénale chronique. CONCLUSIONS: Ces constatations suggèrent que, tout néphroprotecteurs qu'ils soient, les facteurs solubles dérivant de la culture de cellules à croissance précoce provenant de moelle osseuse ont une action de courte durée. En revanche, il apparait qu'une administration répétée de ces facteurs permet d'en prolonger l'action tout en freinant la progression de l'insuffisance rénale chronique dans les modèles expérimentaux.

14.
Case Rep Pathol ; 2014: 961987, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25302128

RESUMO

Acute transplant glomerulopathy transplant glomerulopathy (TG) is a common cause of late renal allograft loss. We describe a unique case of a renal transplant recipient who developed rapid-onset nephrotic-range proteinuria and acute kidney injury secondary to C4d negative acute TG. Two courses of intravenous Rituximab resulted in significant improvement in proteinuria and allograft function. In the setting of acute nephrotic-range proteinuria postrenal allograft, both renal biopsy with electron microscopy and screening for de novo donor-specific antibody should be performed to distinguish atypical presentations of TG from other diagnoses.

15.
PLoS One ; 9(3): e92227, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24637920

RESUMO

The progressive decline of renal function in chronic kidney disease (CKD) is characterized by both disruption of the microvascular architecture and the accumulation of fibrotic matrix. One angiogenic pathway recently identified as playing an essential role in renal vascular development is the stromal cell-derived factor-1α (SDF-1)/CXCR4 pathway. Because similar developmental processes may be recapitulated in the disease setting, we hypothesized that the SDF-1/CXCR4 system would regulate microvascular health in CKD. Expression of CXCR4 was observed to be increased in the kidneys of subtotally nephrectomized (SNx) rats and in biopsies from patients with secondary focal segmental glomerulosclerosis (FSGS), a rodent model and human correlate both characterized by aberration of the renal microvessels. A reno-protective role for local SDF-1/CXCR4 signaling was indicated by i) CXCR4-dependent glomerular eNOS activation following acute SDF-1 administration; and ii) acceleration of renal function decline, capillary loss and fibrosis in SNx rats treated with chronic CXCR4 blockade. In contrast to the upregulation of CXCR4, SDF-1 transcript levels were decreased in SNx rat kidneys as well as in renal fibroblasts exposed to the pro-fibrotic cytokine transforming growth factor ß (TGF-ß), the latter effect being attenuated by histone deacetylase inhibition. Increased renal SDF-1 expression was, however, observed following the treatment of SNx rats with the ACE inhibitor, perindopril. Collectively, these observations indicate that local SDF-1/CXCR4 signaling functions to preserve microvascular integrity and prevent renal fibrosis. Augmentation of this pathway, either purposefully or serendipitously with either novel or existing therapies, may attenuate renal decline in CKD.


Assuntos
Capilares/patologia , Quimiocina CXCL12/metabolismo , Rim/irrigação sanguínea , Receptores CXCR4/metabolismo , Insuficiência Renal Crônica/metabolismo , Insuficiência Renal Crônica/fisiopatologia , Transdução de Sinais , Adulto , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Animais , Benzilaminas , Biópsia , Capilares/efeitos dos fármacos , Capilares/metabolismo , Linhagem Celular , Quimiocina CXCL12/genética , Ciclamos , Fibrose , Glomerulosclerose Segmentar e Focal/tratamento farmacológico , Glomerulosclerose Segmentar e Focal/genética , Glomerulosclerose Segmentar e Focal/patologia , Compostos Heterocíclicos/farmacologia , Compostos Heterocíclicos/uso terapêutico , Humanos , Imuno-Histoquímica , Rim/enzimologia , Rim/patologia , Rim/cirurgia , Testes de Função Renal , Nefrectomia , Óxido Nítrico Sintase Tipo III/metabolismo , Perindopril/farmacologia , Perindopril/uso terapêutico , Fosforilação/efeitos dos fármacos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Endogâmicos F344 , Reação em Cadeia da Polimerase em Tempo Real , Receptores CXCR4/antagonistas & inibidores , Receptores CXCR4/genética , Insuficiência Renal Crônica/tratamento farmacológico , Insuficiência Renal Crônica/patologia , Serina/metabolismo , Transdução de Sinais/efeitos dos fármacos
16.
Artigo em Inglês | MEDLINE | ID: mdl-25780610

RESUMO

PURPOSE OF REVIEW: Chronic kidney disease affects approximately 3 million Canadians. Ongoing investment in high quality kidney research is needed to improve the care of patients with kidney disease. The barriers to translating such research are discussed in this review. SOURCES OF INFORMATION: Personal knowledge, research funding body websites, and published reports. FINDINGS: In this review, we discuss the meaning of the term translational research and present some of the programs aimed at ensuring efficient translation of scientific discoveries with a discussion of the barriers to translation. We highlight some successes and barriers to kidney research translation using recent examples of research in Canadian nephrology. We present the following examples of kidney research: (1) research aimed at identifying the causative genes for inherited kidney diseases; (2) recent discoveries in cell-based therapies for kidney disease; (3) an examination of the impact of acute kidney injury in renal transplant patients; and (4) the development of a kidney failure risk equation to improve prognosis accuracy. LIMITATIONS: This review focuses on research conducted by the authors. IMPLICATIONS: The process of research translation is prolonged and challenging and therefore requires resources, patience, and careful planning. With increased awareness and understanding of the barriers to research translation, researchers and funding bodies can work together to increase the rate at which important research findings reach clinical practice and improve the care of patients with kidney disease.


OBJECTIF DE L'ÉTUDE: La néphropathie chronique touche environ 3 millions de Canadiens. Un investissement soutenu dans la recherche de haute qualité en néphrologie est nécessaire à l'amélioration des soins aux patients. Dans cette étude, nous abordons les obstacles à l'application de ces recherches. SOURCES D'INFORMATION: Les connaissances personnelles, les sites Web d'organismes de financement de la recherche, et les rapports publiés. RÉSULTATS: Dans cette étude, nous traitons de la signification du terme « recherche translationnelle ¼ et présentons certains des programmes visant à assurer une circulation efficace des découvertes scientifiques, en abordant les obstacles à la circulation et à l'application. Nous présentons des réussites de circulation de la recherche en néphrologie, de même que certains obstacles, en recourant à des exemples récents de recherche canadienne en néphrologie. Nous citons les exemples suivants de recherche en néphrologie: (1) la recherche visant à déterminer les gènes responsables des néphropathies héréditaires; (2) les découvertes récentes en matière de thérapies cellulaires pour les néphropathies; (3) l'examen des conséquences d'une insuffisance rénale aiguë chez les patients ayant subi une transplantation rénale; et (4) l'élaboration d'une équation concernant le risque d'insuffisance rénale afin d'améliorer la précision du pronostic. LIMITES DE L'ÉTUDE: L'étude se concentre sur les recherches effectuées par les auteurs. CONSÉQUENCES: Le processus de circulation et d'application de la recherche est long et ardu, si bien qu'il requiert des ressources, de la patience et une planification étroite. Grâce à une compréhension et une sensibilisation accrues des obstacles à la circulation de la recherche, les chercheurs et les organismes de financement peuvent travailler ensemble afin d'accroître le rythme avec lequel les importantes conclusions de recherches atteignent la pratique clinique et améliorent les soins aux patients atteints de néphropathies.

17.
Stem Cells ; 31(11): 2408-19, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23922321

RESUMO

Adult bone marrow-derived cells can improve organ function in chronic disease models, ostensibly by the release of paracrine factors. It has, however, been difficult to reconcile this prevailing paradigm with the lack of cell retention within injured organs and their rapid migration to the reticuloendothelial system. Here, we provide evidence that the salutary antifibrotic effects of bone marrow-derived early outgrowth cells (EOCs) are more consistent with an endocrine mode of action, demonstrating not only the presence of antifibrotic factors in the plasma of EOC-treated rats but also that EOC conditioned medium (EOC-CM) potently attenuates both TGF-ß- and angiotensin II-induced fibroblast collagen production in vitro. To examine the therapeutic relevance of these findings in vivo, 5/6 subtotally nephrectomized rats, a model of chronic kidney and heart failure characterized by progressive fibrosis of both organs, were randomized to receive i.v. injections of EOC-CM, unconditioned medium, or 10(6) EOCs. Rats that received unconditioned medium developed severe kidney injury with cardiac diastolic dysfunction. In comparison, EOC-CM-treated rats demonstrated substantially improved renal and cardiac function and structure, mimicking the changes found in EOC-treated animals. Mass spectrometric analysis of EOC-CM identified proteins that regulate cellular functions implicated in fibrosis. These results indicate that EOCs secrete soluble factor(s) with highly potent antifibrotic activity, that when injected intravenously replicate the salutary effects of the cells themselves. Together, these findings suggest that an endocrine mode of action may underlie the effectiveness of cell therapy in certain settings and portend the possibility for systemic delivery of cell-free therapy.


Assuntos
Células da Medula Óssea/metabolismo , Transplante de Medula Óssea/métodos , Fibrose/cirurgia , Células-Tronco Mesenquimais/metabolismo , Insuficiência Renal Crônica/cirurgia , Animais , Células da Medula Óssea/citologia , Células Cultivadas , Modelos Animais de Doenças , Fibrose/patologia , Citometria de Fluxo , Insuficiência Cardíaca/patologia , Insuficiência Cardíaca/cirurgia , Humanos , Rim/patologia , Masculino , Transplante de Células-Tronco Mesenquimais/métodos , Células-Tronco Mesenquimais/citologia , Fagocitose , Distribuição Aleatória , Ratos , Ratos Endogâmicos F344 , Insuficiência Renal Crônica/patologia
18.
Curr Opin Nephrol Hypertens ; 22(4): 445-51, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23736842

RESUMO

PURPOSE OF REVIEW: Vascular injury is a common contributor to, and complication of, kidney disease. Given the prevalence and importance of vascular injury in renal disease, interest has grown in a novel signaling pathway first identified in developing neurons that also has widespread effects on vascular structure and function, comprising the secreted ligand Slit2 and its cognate Roundabout (Robo) receptors. RECENT FINDINGS: Although initially discovered as a modulator of neuronal migration during development, the Slit2-Robo signaling pathway has recently been found to regulate the structure and function of various subsets of vascular cells and circulating hematopoietic cells that interact with the vessel wall. Through the regulation of intermediate signaling enzymes that control the organization of the actin cytoskeleton, Slit2 and its Robo receptors regulate such diverse processes as angiogenesis, endothelial permeability, vascular smooth muscle cell migration, and thrombosis. SUMMARY: Recent advances in our understanding of Slit2-Robo signaling have provided novel insights into the pathophysiology of vascular injury that is commonly associated with renal disease. These insights have created potential opportunities for the development of new therapies targeting vascular injury associated with renal disease.


Assuntos
Vasos Sanguíneos/metabolismo , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Nefropatias/complicações , Proteínas do Tecido Nervoso/metabolismo , Receptores Imunológicos/metabolismo , Transdução de Sinais , Doenças Vasculares/etiologia , Animais , Vasos Sanguíneos/patologia , Permeabilidade Capilar , Células-Tronco Hematopoéticas/metabolismo , Humanos , Nefropatias/metabolismo , Nefropatias/patologia , Neovascularização Patológica , Doenças Vasculares/metabolismo , Doenças Vasculares/patologia , Proteínas Roundabout
19.
Semin Nephrol ; 32(5): 486-93, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23062990

RESUMO

Cell-based therapy, designed to promote angiogenesis and improve organ function, has been under investigation for the treatment of ischemic heart disease for more than 10 years. Although believed to work primarily by repairing the microvasculature, this form of therapy has not been examined in the setting of chronic kidney disease caused by diabetes in which capillary rarefaction plays a pivotal pathogenetic role. Indeed, despite disease-associated dysfunction, the favorable safety profile of autologous, bone marrow-derived angiogenic cells and their efficacy in animal studies of chronic kidney disease would seem to provide a basis for clinical trials in advanced diabetic nephropathy.


Assuntos
Nefropatias Diabéticas/terapia , Células Endoteliais/transplante , Transplante de Células-Tronco , Animais , Terapia Baseada em Transplante de Células e Tecidos , Humanos , Neovascularização Fisiológica , Células-Tronco
20.
Nephron Extra ; 2(1): 115-24, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22739500

RESUMO

UNLABELLED: BACKGROUND/AIMSBACKGROUND/AIMS: While experimental models that emulate diabetic nephropathy are valuable tools for elucidating pathogenetic mechanisms and developing novel therapies, existing models imperfectly recapitulate human disease. In diabetes, hyperglycemia and hemodynamic forces act in concert to induce renal injury. Accordingly, in the present study, we combined streptozotocin-induced diabetes with surgical ablation of 5/6 of the kidney mass with the aim of evaluating their additive effects on renal function and glomerular morphology. METHODS: Female F344 rats were randomized to undergo subtotal nephrectomy (SNx) either at baseline or following 4 weeks of diabetes. RESULTS: In comparison to sham rats, rats with diabetes or rats after SNx surgery, diabetic subtotally nephrectomized (DM-SNx) rats demonstrated an increase in systolic blood pressure, glomerular volume and mesangial matrix. Albuminuria was synergistically increased by hyperglycemia and renal mass ablation associated with decreased nephrin expression. In contrast, glomerular capillary rarefaction and glomerular filtration rate were similarly reduced in SNx and DM-SNx rats. CONCLUSION: The DM-SNx rat recapitulates some of the features of human disease, most notably augmented albuminuria. Since this model avoids the deletion or overexpression of gene(s) linked to the pathogenesis of nephropathy, the DM-SNx rat model represents a complementary tool for the trial of novel therapies.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA